LRRK2 G2019S variant is associated with transcriptional changes in Parkinson's disease human myeloid cells under proinflammatory environment
Elisa Navarro, Anastasia G. Efthymiou, Daniele Mattei, Madison Parks, Giulietta Maria Riboldi, Ricardo A. Vialle, Evan Udine, Benjamin Z. Muller, Jack Humphrey, Amanda Allan, Charalambos Argyrou, Katia P Lopes, Alexandra Münch, Deborah Raymond, Rivka Sachdev, , Towfique Raj
This study shows the G2019S LRRK2 mutation alters transcriptomes of myeloid cells under proinflammatory conditions, affecting lipid metabolism and phagocytic function.
Journal of Neuroinflammation · Aug 8, 2026Peer-reviewedGenetics